4-Methylcatechol-induced oxidative stress induces intrinsic apoptotic pathway in metastatic melanoma cells

Biochemical Pharmacology

Volumn 81, Issue 10, 2011, Pages 1211-1218

  Payton, Florastina ^b   Bose, Rumu ^a   Alworth, William L ^c   Kumar, Addanki P ^a   Ghosh, Rita ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b XAVIER UNIVERSITY OF LOUISIANA   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

4 Methylcatechol; Apoptosis; Cell cycle arrest; Melanoma; Reactive oxygen species; Survival

Indexed keywords

4 METHYLCATECHOL; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA CELL; METASTASIS; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CATECHOLS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; MELANOMA; NEOPLASM METASTASIS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 79955472023     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.03.005     Document Type: Article

References (40)

1. V.D. Criscione, and M.A. Weinstock Melanoma thickness trends in the United States, 1988-2006 J Invest Dermatol 130 3 2010 793 797 [Epub 2009 October 15]
2. M.G. Cockburn, J. Zadnick, and D. Deapen Developing epidemic of melanoma in the Hispanic population of California Cancer 106 5 2006 1162 1168
3. F.S. Hodi, S.J. O'Day, D.F. McDermott, R.W. Weber, J.A. Sosman, and J.B. Haanen Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 363 8 2010 711 723
4. K.T. Flaherty, I. Puzanov, K.B. Kim, A. Ribas, G.A. McArthur, and J.A. Sosman Inhibition of mutated, activated BRAF in metastatic melanoma N Engl J Med 363 9 2010 809 819
5. http://www.nal.usda.gov/fnic/foodcomp, USDA Database for the flavonoid content of selected foods date accessed 08/2010.
6. S.H. Häkkinen, S.O. Kärenlampi, I.M. Heinonen, H.M. Mykkänen, and A.R. Törrönen Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries J Agric Food Chem 47 6 1999 2274 2279 (Pubitemid 29325110)
7. K. Morita, H. Arimochi, and Y. Ohnishi In vitro cytotoxicity of 4-methylcatechol in murine tumor cells: induction of apoptotic cell death by extracellular pro-oxidant action J Pharmacol Exp Ther 306 1 2003 317 323 [Epub 2003 April 3] (Pubitemid 36734387)
8. R. Ghosh, A.M. Ott, D. Seetharam, T.J. Slaga, and A.P. Kumar Cell cycle block and apoptosis induction in a human melanoma cell line following treatment with 2-methoxyoestradiol: therapeutic implications? Melanoma Res 13 2 2003 119 127 (Pubitemid 36583973)
9. R. Ghosh, N. Nadiminty, J.E. Fitzpatrick, W.L. Alworth, T.J. Slaga, and A.P. Kumar Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity J Biol Chem 280 7 2005 5812 5819 [Epub 2004 December 1] (Pubitemid 40280062)
10. A. Krishan Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining J Cell Biol 66 1975 188 193
11. A.P. Kumar, G.E. Garcia, R. Ghosh, R.V. Rajnarayanan, W.L. Alworth, and T.J Slaga 4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management Neoplasia 5 3 2003 255 266 (Pubitemid 36754055)
12. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Anal Biochem 72 1976 248 254
13. G. Glässer, E.U. Graefe, F. Struck, M. Veit, and R. Gebhardt Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites Phytomedicine 9 1 2002 33 40 (Pubitemid 34184207)
14. S. Jagtap, K. Meganathan, V. Wagh, J. Winkler, J. Hescheler, and A. Sachinidis Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases Curr Med Chem 16 12 2009 1451 1462
15. M. Sasaki, H. Nakamura, S. Tsuchiya, S. Horie, M. Kashiwayanagi, and T. Saito Quercetin-induced PC12 cell death accompanied by caspase-mediated DNA fragmentation Biol Pharm Bull 30 4 2007 682 686 (Pubitemid 46570988)
16. T.W. Nam, C.I. Yoo, H.T. Kim, C.H. Kwon, J.Y. Park, and Y.K. Kim The flavonoid quercetin induces apoptosis and inhibits migration through a MAPK-dependent mechanism in osteoblasts J Bone Miner Metab 26 6 2008 551 560 [Epub 2008 November 1]
17. F. Brisdelli, C. Coccia, B. Cinque, M.G. Cifone, and A. Bozzi Induction of apoptosis by quercetin: different response of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells Mol Cell Biochem 296 1-2 2007 137 149 [Epub 2006 September 13]
18. W. Chen, X. Wang, J. Zhuang, L. Zhang, and Y. Lin Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells Carcinogenesis 28 10 2007 2114 2121 [Epub 2007 June 4] (Pubitemid 47543370)
19. U. Kaindl, I. Eyberg, N. Rohr-Udilova, C. Heinzle, and B. Marian The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage Food Chem Toxicol 46 4 2008 1320 1326 [Epub 2007 September 11] (Pubitemid 351258201)
20. T. Fujii, and M. Saito Inhibitory effect of quercetin isolated from rose hip (Rosa canina L.) against melanogenesis by mouse melanoma cells Biosci Biotechnol Biochem 73 9 2009 1989 1993 [Epub 2009 September 7]
21. R. Kale, M. Saraf, A. Juvekar, and P. Tayade Decreased B16F10 melanoma growth and impaired tumour vascularization in BDF1 mice with quercetin-cyclodextrin binary system J Pharm Pharmacol 58 10 2006 1351 1358 (Pubitemid 44580565)
22. T. Thangasamy, S. Sittadjody, G.C. Mitchell, E.E. Mendoza, V.M. Radhakrishnan, and K.H. Limesand Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73 BMC Cancer 10 2010 282
23. T. Thangasamy, S. Sittadjody, S. Lanza-Jacoby, P.R. Wachsberger, K.H. Limesand, and R. Burd Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase Nutr Cancer 59 2 2007 258 268 (Pubitemid 350230743)
24. L.T. Zheng, G.M. Ryu, B.M. Kwon, W.H. Lee, and K. Suk Anti-inflammatory effects of cetechols in lipopolysaccharide-stimulated microglia cells: inhibition of microglial neurotoxicity Eur J Pharmacol 588 2008 106 113 [Epub 2008 April 18]
25. S. O'Day, R. Gonzalez, D. Lawson, R. Weber, L. Hutchins, and C. Anderson Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma J Clin Oncol 27 32 2009 5452 5458 [Epub 2009 October 13]
26. J.R. Kirshner, S. He, V. Balasubramanyam, J. Kepros, C.Y. Yang, and M. Zhang Elesclomol induces cancer cell apoptosis through oxidative stress Mol Cancer Ther 7 8 2008 2319 2327
27. P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, and E.S. Alnemri Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 4 1997 479 489 (Pubitemid 27508237)
28. J. Rodriguez, and Y. Lazebnik Caspase-9 and APAF-1 form an active holoenzyme Genes Dev 13 24 1999 3179 3184 (Pubitemid 30030439)
29. M.S. Soengas, and S.W. Lowe Apoptosis and melanoma chemoresistance Oncogene 22 20 2003 3138 3151 (Pubitemid 36713766)
30. S.R. Datta, A. Brunet, and M.E. Greenberg Cellular survival: a play in three Akts Genes Dev 13 22 1999 2905 2927
31. P. Dhawan, A.B. Singh, D.L. Ellis, and A. Richmond Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappa B and tumor progression Cancer Res 62 24 2002 7335 7342 (Pubitemid 36025257)
32. J.M. Stahl, A. Sharma, M. Cheung, M. Zimmerman, J.Q. Cheng, and M.W. Bosenberg Deregulated Akt3 activity promotes development of malignant melanoma Cancer Res 64 19 2004 7002 7010 (Pubitemid 39331010)
33. J. Downward PI 3-kinase, Akt and cell survival Semin Cell Dev Biol 15 2 2004 177 182 (Pubitemid 38251646)
34. D.R. Plas, and C.B. Thompson Akt-dependent transformation: there is more to growth than just surviving Oncogene 24 50 2005 7435 7442 (Pubitemid 41637983)
35. B. Stiles, M. Groszer, S. Wang, J. Jiao, and H. Wu PTENless means more Dev Biol 273 2 2004 175 184 (Pubitemid 39144393)
36. S.R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, and Y. Gotoh Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 2 1997 231 241 (Pubitemid 27456390)
37. M.H. Cardone, N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, and E. Stanbridge Regulation of cell death protease caspase-9 by phosphorylation Science 282 5392 1998 1318 1321 (Pubitemid 28524494)
38. L.D. Mayo, and D.B. Donner A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus Proc Natl Acad Sci U S A 98 20 2001 11598 11603 [Epub 2001 August 14] (Pubitemid 32928774)
39. T.M. Gottlieb, J.F. Leal, R. Seger, Y. Taya, and M. Oren Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis Oncogene 21 8 2002 1299 1303 (Pubitemid 34185247)
40. M. Krasilnikov, V. Adler, S.Y. Fuchs, Z. Dong, A. Haimovitz-Friedman, and M. Herlyn Contribution of phosphatidylinositol 3-kinase to radiation resistance in human melanoma cells Mol Carcinog 24 1 1999 64 69 (Pubitemid 29070245)